Results 71 to 80 of about 52,111 (191)

Serotonin and fluoxetine levels in plasma and platelets after fluoxetine treatment in depressive patients

, 2002
Depression is a mood disorder characterized by complex alterations of neurotransmitters such as serotonin, norepinephrine, and dopamine. In particular, there is substantial evidence of abnormalities in serotonin neurotransmission.
DELL'ERBA A., CASTROGIOVANNI P., AUTERI A., DI MURO A., DE LALLA A., LEO A., IAPICHINO S., BLARDI P.   +7 more
core   +1 more source

Fluoxetine Overdose-Induced Seizure [PDF]

, 2008
A 37-year-old woman experienced a witnessed generalized seizure in the Emergency Department three hours after ingesting approximately 1400 mg of fluoxetine in a suicide attempt.
Suchard, Jeffrey R
core   +1 more source

Initiation of fluoxetine in a pediatric patient with Mucopolysaccharidosis IIIA: Early observations

Molecular Genetics and Metabolism Reports
Fluoxetine has been identified as a potential treatment for mucopolysaccharidosis IIIA (MPS IIIA), a debilitating and progressive lysosomal storage disorder for which no treatments are approved.
Lindsay Torrice, Elizabeth Jalazo
doaj   +1 more source

Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial

, 2012
SN Hashemi1, HR Ghafarian Shirazi2,3, A Mohamadi4, GH Zadeh-Bagheri5, KH Noorian5, M Malekzadeh21Department of Psychiatry, Faculty of Medicine, 2Research Center of Social Factors Affecting Health, Yasuj University of Medical Sciences, Yasuj, 3School of ...
Noorian KH, Malekzadeh M, Mohammadi A, Hashemi SN, Ghafarian Shirazi HR, Zadeh-Bagheri GH   +5 more
core  

Fluoxetine prevents Aβ1-42-induced toxicity via a paracrine signaling mediated by Transforming-Growth-Factor-β1

Frontiers in Pharmacology, 2016
Selective reuptake inhibitors (SSRIs), such as fluoxetine and sertraline, increase circulating Transforming-Growth-Factor-β1 (TGF-ß1) levels in depressed patients,and are currently studied for their neuroprotective properties in Alzheimer’s disease (AD).
Filippo Caraci, Filippo Caraci, Fabio Tascedda, Sara Merlo, Cristina Benatti, Simona Federica Spampinato, Antonio Munafò, Gian Marco Leggio, Ferdinando Nicoletti, Ferdinando Nicoletti, Nicoletta Brunello, Filippo Drago, Maria Angela Sortino, Agata Copani, Agata Copani   +14 more
doaj   +1 more source

Effects of fluoxetine on brain-derived neurotrophic factor serum concentration and cognition in patients with vascular dementia

, 2014
Xuan Liu,1,2 Junjian Zhang,1 Dong Sun,1 Yuanteng Fan,1 Hongbin Zhou,2 Binfang Fu21Department of Neurology, Zhongnan Hospital, Wuhan University, Wuhan, 2Department of Neurology, Xiangyang Central Hospital, Medical College, Hubei University of Arts and ...
Liu X, Zhang JJ, Fan YT, Fu BF, Sun D, Zhou HB   +5 more
core  

Fluoxetine Dose and Administration Method Differentially Affect Hippocampal Plasticity in Adult Female Rats

Neural Plasticity, 2014
Selective serotonin reuptake inhibitor medications are one of the most common treatments for mood disorders. In humans, these medications are taken orally, usually once per day. Unfortunately, administration of antidepressant medications in rodent models
Jodi L. Pawluski, Eva van Donkelaar, Zipporah Abrams, Virginie Houbart, Marianne Fillet, Harry W. M. Steinbusch, Thierry D. Charlier   +6 more
doaj   +1 more source

Effect and mechanism of fluoxetine on electrophysiology in vivo in a rat model of postmyocardial infarction depression

, 2015
Jinjun Liang,1,2 Xiaoran Yuan,1,2 Shaobo Shi,1,2 Fang Wang,1,2 Yingying Chen,1,2 Chuan Qu,1,2 Jingjing Chen,1,2 Dan Hu,1–3 Yang Bo1,2 1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, People’s Republic of China ...
Qu C, Hu D, Shi S, Chen J, Liang J, Wang F, Chen Y, Yang B, Yuan X   +8 more
core  

Fluoxetine does not enhance visual perceptual learning and triazolam specifically impairs learning transfer

Frontiers in Human Neuroscience, 2016
The selective serotonin reuptake inhibitor fluoxetine significantly enhances adult visual cortex plasticity within the rat. This effect is related to decreased gamma-aminobutyric acid (GABA) mediated inhibition and identifies fluoxetine as a potential ...
Alice Kitty Lagas, Joanna Mary Black, Winston D. Byblow, Melanie Kate Fleming, Melanie Kate Fleming, Lucy Goodman, Rob Kydd, Bruce Russell, Bruce Russell, Cathy Stinear, Benjamin Thompson, Benjamin Thompson   +11 more
doaj   +1 more source

A study on the effect of atorvastatin on the pharmacokinetic and antidepressant activity of fluoxetine

National Journal of Physiology, Pharmacy and Pharmacology, 2017
Background: Polypharmacy is of wide concern in drug interaction. It is the leading cause of adverse drug reaction, and consequently, increasing the possibility of hospitalization and escalating the cost of care. The incidence of coexisting depression and
Bimbishar Bhattarai, Shivakumar Swamy, Sanjay Raj Baral, Chandra Prakash Acharya   +3 more
doaj   +1 more source